Keros Therapeutics, Inc. (KROS): Shares Outstanding
19.54M
As of 2025-12-31
19.83M
As of 2026-06-30
-10.8%
3-year compound annual growth
-3.4%
5-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 19.54M | -51.8% | 2026-03-04, Balance as of period end |
| 2024-12-31 | 40.55M | +27.4% | 2026-03-04, Balance as of period end |
| 2023-12-31 | 31.84M | +15.6% | 2025-02-26, Balance as of period end |
| 2022-12-31 | 27.54M | +14.9% | 2024-02-28, Balance as of period end |
| 2021-12-31 | 23.97M | +3.4% | 2023-03-03, Balance as of period end |
| 2020-12-31 | 23.19M | n/c | 2022-03-09, Balance as of period end |
| 2019-12-31 | 2.43M | n/a | 2021-03-25, Balance as of period end |